Ondansetron treatment in a child presenting with chronic intractable pruritus
- PMID: 17149457
- PMCID: PMC2673141
- DOI: 10.1155/2006/873870
Ondansetron treatment in a child presenting with chronic intractable pruritus
Abstract
The case of a seven-year-old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors.
Est présenté le cas d’un garçon de sept ans atteint d’un prurit chronique secondaire à un naevus mélanocytique géant congénital. Le prurit n’a pas répondu à un traitement classique aux antipruritiques, mais a répondu à l’ondansétron, un antagoniste sélectif des récepteurs 5-hydroxytryptamine de type 3.
References
-
- Koeller JM, Aapro MS, Gralla RJ, et al. Antiemetic guidelines: Creating a more practical treatment approach. Support Care Cancer. 2002;10:519–22. - PubMed
-
- Gan TJ, Meyer T, Apfel CC, et al. Department of Anesthesiology, Duke University Medical Center Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg. 2003;97:62–71. - PubMed
-
- Tzeng JI, Chu KS, Ho ST, Cheng KI, Liu KS, Wang JJ. Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control. Can J Anaesth. 2003;50:1023–6. - PubMed
-
- Charuluxananan S, Kyokong O, Somboonviboon W, Narasethakamol A, Promlok P. Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesth Analg. 2003;96:1789–93. - PubMed
-
- Borgeat A, Stirnemann HR. Ondansetron is effective to treat spinal or epidural morphine-induced pruritus. Anesthesiology. 1999;90:432–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
